Drug transportation is impeded by various barriers in the hypoxic solid
tumor, resulting in compromised anticancer efficacy. Herein, a solid
lipid monostearin (MS)-coated CaO2/MnO2 nanocarrier was designed to optimize
doxorubicin (DOX) transportation comprehensively for
chemotherapy enhancement. The MS shell of nanoparticles could be destroyed selectively by highly-expressed
lipase within
cancer cells, exposing water-sensitive cores to release DOX and produce O2. After the
cancer cell death, the core-exposed nanoparticles could be further liberated and continue to react with water in the
tumor extracellular matrix (ECM) and thoroughly release O2 and DOX, which exhibited cytotoxicity to neighboring cells. Small DOX molecules could readily diffuse through ECM, in which the
collagen deposition was decreased by O2-mediated
hypoxia-inducible factor-1 inhibition, leading to synergistically improved
drug penetration. Concurrently, DOX-efflux-associated
P-glycoprotein was also inhibited by O2, prolonging
drug retention in
cancer cells. Overall, the DOX transporting processes from nanoparticles to deep
tumor cells including drug release, penetration, and retention were optimized comprehensively, which significantly boosted antitumor benefits.